The ubiquitin ligase Siah2 regulates obesity-induced adipose tissue inflammation by Kilroy, Gail et al.
Louisiana State University 
LSU Digital Commons 
Faculty Publications Department of Biological Sciences 
1-1-2015 
The ubiquitin ligase Siah2 regulates obesity-induced adipose 
tissue inflammation 
Gail Kilroy 
Pennington Biomedical Research Center 
Lauren E. Carter 
Pennington Biomedical Research Center 
Susan Newman 
Pennington Biomedical Research Center 
David H. Burk 
Pennington Biomedical Research Center 
Justin Manuel 
Pennington Biomedical Research Center 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.lsu.edu/biosci_pubs 
Recommended Citation 
Kilroy, G., Carter, L., Newman, S., Burk, D., Manuel, J., Möller, A., Bowtell, D., Mynatt, R., Ghosh, S., & Floyd, Z. 
(2015). The ubiquitin ligase Siah2 regulates obesity-induced adipose tissue inflammation. Obesity, 23 
(11), 2223-2232. https://doi.org/10.1002/oby.21220 
This Article is brought to you for free and open access by the Department of Biological Sciences at LSU Digital 
Commons. It has been accepted for inclusion in Faculty Publications by an authorized administrator of LSU Digital 
Commons. For more information, please contact ir@lsu.edu. 
Authors 
Gail Kilroy, Lauren E. Carter, Susan Newman, David H. Burk, Justin Manuel, Andreas Möller, David D. 
Bowtell, Randall L. Mynatt, Sujoy Ghosh, and Z. Elizabeth Floyd 
This article is available at LSU Digital Commons: https://digitalcommons.lsu.edu/biosci_pubs/724 
The Ubiquitin Ligase Siah2 Regulates Obesity-Induced
Adipose Tissue Inflammation
Gail Kilroy1, Lauren E. Carter1, Susan Newman1, David H. Burk1, Justin Manuel1, Andreas M€oller2, David D. Bowtell3,
Randall L. Mynatt1, Sujoy Ghosh1,4, and Z. Elizabeth Floyd1
Objective: Chronic, low-grade adipose tissue inflammation associated with adipocyte hypertrophy is an
important link in the relationship between obesity and insulin resistance. Although ubiquitin ligases regu-
late inflammatory processes, the role of these enzymes in metabolically driven adipose tissue inflamma-
tion is relatively unexplored. Herein, the effect of the ubiquitin ligase Siah2 on obesity-related adipose
tissue inflammation was examined.
Methods: Wild-type and Siah2KO mice were fed a low- or high-fat diet for 16 weeks. Indirect calorime-
try, body composition, and glucose and insulin tolerance were assayed along with glucose and insulin
levels. Gene and protein expression, immunohistochemistry, adipocyte size distribution, and lipolysis
were also analyzed.
Results: Enlarged adipocytes in obese Siah2KO mice were not associated with obesity-induced insulin
resistance. Proinflammatory gene expression, stress kinase signaling, fibrosis, and crown-like structures
were reduced in the Siah2KO adipose tissue, and Siah2KO adipocytes were more responsive to insulin-
dependent inhibition of lipolysis. Loss of Siah2 increased expression of PPARc target genes involved in
lipid metabolism and decreased expression of proinflammatory adipokines regulated by PPARc.
Conclusions: Siah2 links adipocyte hypertrophy with adipocyte dysfunction and recruitment of proinflam-
matory immune cells to adipose tissue. Selective regulation of PPARc activity is a Siah2-mediated mech-
anism contributing to obesity-induced adipose tissue inflammation.
Obesity (2015) 23, 2223–2232. doi:10.1002/oby.21220
Introduction
Obesity-associated insulin resistance is linked to dysregulation of
lipid storage and chronic, low-grade inflammation of adipose tis-
sue (1). As adipose tissue expands to accommodate the lipid stor-
age demands of excess energy intake, adipocyte hypertrophy
becomes a defining characteristic. When the capacity to expand is
exceeded, inflammatory signaling in adipose tissue is activated
(2). Adipocyte secretion of proinflammatory adipokines correlates
with infiltration of M1-like macrophages and proinflammatory T
lymphocytes (1), setting up an inflammatory state focused on
removing necrotic adipocytes (3). Accompanied by increased
release of fatty acids from adipose tissue, this leads to impaired
insulin signaling in skeletal muscle and liver and systemic insulin
resistance (4).
Adipose tissue inflammation is sustained by a positive feedback
loop in which cytokines secreted by infiltrating macrophages acti-
vate stress kinase signaling pathways in adipocytes and macrophages
that up-regulate proinflammatory genes via activator protein-1
(AP-1) and nuclear factor-jB (NF-jB) transcriptional activity (5).
Although signaling events controlling NF-jB activation (6) are regu-
lated by enzymes of the ubiquitin–proteasome system, involvement
of the ubiquitin–proteasome system in obesity-induced adipose tis-
sue inflammation is relatively unexplored.
Post-translational modification of proteins by ubiquitin, the major
pathway controlling non-lysosomal intracellular protein degradation,
begins with ubiquitin binding to the ubiquitin activating enzyme
(E1), followed by transfer of ubiquitin from E1 to the targeted pro-
tein via ubiquitin conjugating enzymes (E2s) and ubiquitin ligases
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(E3s), which determine the specificity of ubiquitylation (7). Deletion
of E3 ligases c-Cbl (8) or ITCH (9), an E3 ligase involved in T-cell
differentiation, increases energy expenditure and prevents high fat-
induced obesity. Our studies in 3T3-L1 adipocytes found the ubiqui-
tin ligase mammalian homologue of seven-in-absentia-2 (Siah2)
alters peroxisome proliferator-activated receptor c (PPARc) protein
levels and selectively regulates PPARc activity (10). Given the cen-
tral role of PPARc in forming and maintaining adipocytes, regulat-
ing insulin sensitivity, and inflammatory gene expression in adipo-
cytes and macrophages (11), we hypothesized that Siah2 regulates
obesity-induced changes in adipose tissue. In this study, we exam-
ined the adipose tissue phenotype in global Siah2-null mice chal-
lenged with chronic excess energy intake.
Methods
Experimental animals
Siah2KO mice were generated and maintained as described (12,13).
All animal experiments were approved by the Pennington Biomedical
Research Center Animal Care and Use Committee. The animals were
housed with a 12-h light–dark cycle at 248C. At four weeks of age,
wild-type (WT) and Siah2KO male mice were randomly assigned
(n 5 10/group) to a defined 10% low-fat diet (LFD) or 45% high-fat
diet (HFD) and were fed ad libitum for 4 months thereafter. Body
weight was measured weekly and body composition was measured bi-
weekly by NMR. Food intake, activity, and indirect calorimetry were
measured at 12 weeks on each diet (TSE PhenoMaster). At the end of
the study, the mice were euthanized between 8 and 11 am. Adipose
tissue was harvested for analysis of adipocyte size distribution and
lipolysis from a separate cohort of WT and Siah2KO male mice main-
tained on LFD or HFD for 2 months.
Glucose and insulin tolerance tests
For the glucose (GTT) and insulin (ITT) tolerance tests, the amount
of glucose or insulin administered was normalized to fat-free mass
(FFM) (14), which did not vary significantly among groups
(20.1 6 0.13 g) at 12 weeks on each diet. Mice were fasted 4 h prior
to administering 2 g/kg FFM of glucose/mouse (GTT) or 1 U/kg
lean mass insulin/mouse (HumulinR) (ITT) by intraperitoneal
injection.
Blood chemistry and lipolysis
Fasting serum glucose levels were measured by hexokinase activity
assay (Sigma). Fasting insulin levels were assayed via ELISA (Crys-
tal Chem). Serum nonesterified fatty acids (Abcam) and triglycerides
(Eagle Diagnostics) levels were assayed according to manufacturers’
instructions. For lipolysis assays, adipocytes were isolated by colla-
genase treatment from epididymal adipose tissue of HFD-fed mice
(15). Insulin-mediated inhibition of lipolysis in the presence of iso-
proterenol (0.1 lM) was assessed by glycerol release (Zen-Bio).
Microarray analysis
Epididymal adipose tissue RNA (RNA integrity number 8) was
analyzed for gene expression on Illumina MouseRef-8v2.0 expres-
sion arrays. RNA from 8 to 10 animals/group was combined into
three pooled samples/group. Raw gene expression signals were
background adjusted and quantile normalized using GenomeStudio
(V2011.1.Illumina Inc.). For each sample, probes were considered
“expressed” if their detection P-value was <0.05. Probes that failed
to reach a detection P-value <0.05 in any sample across the four
treatments (WT high fat, low fat; Siah2KO high fat, low fat) were
removed from analysis. Remaining probes were log transformed
(base 2) and treatment specific fold-changes computed as log ratios.
The statistical significance of differential expression was ascertained
by regularized t-test, based on a Bayesian probabilistic framework
(16). Genes with an absolute fold-change 1.5-fold and P 0.001
were considered significantly differentially expressed, unless other-
wise noted. Biological pathway analysis was conducted on the gene
expression signals using gene-set enrichment (GSEA) or over-
representation based approaches (Ingenuity Pathway Analysis, Inge-
nuity). Statistical analyses were controlled for multiple testing via
the false discovery rate (FDR) (17). The microarray dataset was sub-
mitted to Gene Expression Omnibus (GEO) data repository
(GSE61839).
Quantitative PCR
Total RNA was purified from epididymal adipose tissue, (200 ng)
reverse transcribed and real-time PCR performed with TaqMan
chemistry as described (10). The results were normalized to ubiqui-
tin B mRNA levels and analyzed by the 22DDCT method with WT
values used as the calibrator. The gene list is provided in Supporting
Information Table S1.
Preparation of whole cell extracts and
immunoblotting
Adipose tissue was homogenized in a denaturing buffer and proc-
essed for immunoblotting or immunoprecipitation as described (10).
Nitrocellulose membranes were incubated with antibodies (Support-
ing Information Table S2) for 1-2 h at room temperature or over-
night at 48C.
Immunohistochemistry and immunostaining
Epididymal adipose tissue was fixed in 10% formalin, then embed-
ded in paraffin, sectioned onto slides and hematoxylin and eosin
(H&E) stained. Adipose tissue collagen content was determined by
trichrome staining and macrophage content by immunodetection
using anti-Iba1 antibody.
Adipocyte area and size distribution
H&E stained inguinal and epididymal adipose tissue were analyzed
using Image J software programmed to measure the area of each
adipocyte based on size and shape exclusion limits. The number of
adipocytes counted/experimental condition ranged from 2,639-
14,819. Epididymal adipocyte size distribution was determined as
described (18) and analyzed on a Multisizer-3 (Beckman Coulter)
using a 400-lm aperture with a dynamic linear range 12-320 lm
and reported as the mean at 20 lm intervals from 22 to 240 lm.
Statistical analysis
Normal distribution of glucose and insulin levels, food intake, and
body weight was assessed using the D’Agostino-Pearson omnibus
normality test. Statistical significance for body weight, GTT, and ITT
was determined using ANOVA. Statistical significance for all other
data was determined using an unpaired two-tailed t-test. JMP Pro
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10.0 (SAS Institute) and GraphPad Prism 5 software were used for
statistical analyses. Variability was expressed as the mean 6 SEM.
Results
Siah2 regulates energy expenditure in
diet-induced obesity
To characterize the role of Siah2 in obesity, we conducted a feed-
ing study with a 10% LFD or 45% HFD diet for 4 months. Based
on our studies in 3T3-L1 adipocytes showing Siah2 promotes adi-
pogenesis (10), we anticipated loss of Siah2 in vivo would lead to
reduced body weight and fat mass (FM), and that Siah2KO mice
would develop insulin resistance more readily than WT mice when
fed HFD. However, HFD Siah2KO mice body weight trended
higher than WT and body weight for the LFD Siah2KO mice was
significantly higher than WT mice until late in the study (Figure
1A). After 8 weeks, there was no significant difference in the per-
cent FM within each diet group (Figure 1B), but percent FFM was
lower in the Siah2KO LFD mice at 4 and 12 weeks (Figure 1C).
Food intake was unaffected by genotype (Figure 1D), although
body weight positively correlated with food intake for both groups
on the HFD (Supporting Information Figure S1A). Energy expendi-
ture was measured after 12 weeks on each diet. Genotype had no
effect on energy expenditure in the LFD-fed mice. However, unlike
WT, energy expenditure of the Siah2KO mice did not increase
with HFD (Figure 1E) and loss of Siah2 had a significant effect on
the relationship between energy expenditure and body weight or
lean mass in the HFD-fed mice (Figure 1F). HFD Siah2KO mice
activity was significantly lower than WT (Supporting Information
Figure S1C). When the reduced activity of the HFD Siah2KO mice
was considered, lower energy expenditure in the Siah2KO mice
was largely accounted for by genotype, FFM, and activity using
analysis of covariance (19). However, the effect of genotype on
energy expenditure remained significant, suggesting Siah2 also
affects energy expenditure independent of body composition or
activity (Figure 1F).
Figure 1 Siah2KO mice fed HFD are obese with reduced energy expenditure compared to WT. (A) Body weight, (B) percent FM, and (C) percent FFM were meas-
ured in the WT and Siah2KO mice fed a defined LFD or HFD over 16 weeks. (D) Food intake and (E) energy expenditure were measured at 12 weeks on each diet.
Dark bars indicate 7P-7A. (F) Regression analysis of energy expenditure (kcal/h) related to body weight or FFM (lean mass) was carried out using the daily energy
expenditure of each animal over three consecutive days. Activity and RER were also measured (Supporting Information Figure S1). Statistical significance compared
to WT, *P< 0.05.
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Obese Siah2KO mice have improved insulin
sensitivity
To investigate the adipose tissue of the Siah2KO mice, we carried out
H&E staining of the epididymal fat pad. Adipocytes from obese
Siah2KO mice were hypertrophied but more uniform in size and shape
than obese WT adipocytes (Figure 2A). Adipocyte area measurements
indicated Siah2KO adipocytes trended larger than WT adipocytes
independent of diet or fat depot (Figure 2B). Analysis of adipocyte
size distribution after 2 months on LFD or HFD shows the shift toward
larger adipocytes began earlier in the Siah2KO mice than WT (Figure
2C), consistent with Siah2 affecting adipocyte size independent of
diet, body weight, or FM. However, circulating free fatty acid and tri-
glyceride levels were significantly lower in the LFD- and HFD-fed
Siah2KO mice, and triglyceride levels were lower in the obese
Siah2KO mice compared to WT (Figure 2D). This suggests the hyper-
trophied Siah2KO adipocytes were less lipolytic. To test this, adipo-
cytes were isolated from obese WT and Siah2KO mice and assayed
for insulin-mediated inhibition of adrenergic-stimulated lipolysis.
Siah2KO adipocytes were significantly more sensitive to insulin-
mediated inhibition of lipolysis (Figure 2E).
The lower free fatty acid levels corresponded to lower blood glucose
levels in the Siah2KO mice, and the glucose levels did not increase
with obesity in the absence of Siah2 (Figure 3A). Fasting insulin
levels trended lower in the lean Siah2KO mice compared to lean
WT mice and increased with diet-induced obesity, but they remained
significantly lower than WT (Figure 3B). Although insulin levels in
the Siah2KO mice increased with obesity, glucose (Figure 3C,D)
and insulin tolerance (Figure 3E,F) tests showed loss of Siah2
Figure 2 Siah2KO adipocytes are enlarged but more insulin-sensitive than WT. (A) H&E staining of HFD WT and Siah2KO epididymal fat. (B) Adipocyte size
(area) quantitated using Image J. iWAT, inguinal adipose tissue, eWAT, epididymal adipose tissue. (C) Adipocyte size distribution of epididymal adipocytes at
2 months on LFD or HFD analyzed using Coulter counting. (D) WT and Siah2KO (KO) serum-free fatty acids and triglyceride levels. (E) Insulin-dependent inhi-
bition of lipolysis in isolated HFD WT and Siah2KO epididymal adipocytes. Statistical significance compared to WT, *P< 0.05; **P< 0.01; ***P< 0.001. [Color
figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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improved glucose tolerance and insulin sensitivity in the lean and
obese mice. Notably, glucose and insulin tolerance in the obese
Siah2KO mice was comparable to lean WT, indicating Siah2 con-
tributes to the negative effects of obesity-induced adipocyte hyper-
trophy on glucose metabolism.
Siah2KO mice have reduced adipose tissue
inflammation
To begin understanding the mechanism underlying the effect of
Siah2 on insulin sensitivity and adipocyte size, we conducted micro-
array analysis of Siah2KO and WT epididymal adipose tissue. The
most significant differences in gene expression were related to
inflammatory responses, hematological function, and immune cell
trafficking (P< 0.02) (Figure 4A). Specifically, pathways related to
Toll-like receptor signaling, B- and T-cell receptor signaling, and
natural killer cell-mediated cytotoxicity were significantly down-
regulated (P< 0.01) in HFD-fed Siah2KO adipose, compared to WT
samples (Supporting Information Table S3). Hierarchical clustering
of the top 50 differentially expressed transcripts showed down-
regulation of a broad range of genes involved in proinflammatory
responses (Figure 4B).
Figure 3 Carbohydrate metabolism is improved in the lean or obese Siah2KO mice. (A) Fasting blood glucose and (B) insulin
levels assayed at 16 weeks on the LFD or HFD. (C) GTT and (D) GTT AUC and (E) ITT and (F) ITT AUC at 12 weeks on each
diet. Statistical significance compared to WT, #P< 0.05 for LFD and *P< 0.05; **P < 0.01 for HFD.
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Adipose tissue expression of macrophage markers, including F4/80,
cd68, cd11c, cd11d, trem2, and Tyrobp, was reduced in the visceral
adipose tissue of the obese Siah2KO mice (Figure 5A). Although
proinflammatory markers were decreased (F4/80, cd11c, cd11d),
expression of Arg-1, an indicator of anti-inflammatory macrophage,
was increased. Expression of proinflammatory cytokines, including
tnfa, ccl2, ccr2 (CCL2 receptor), gdf3, saa3, and pai-1, were also
significantly reduced in the Siah2KO adipose tissue (Figure 5B, full
gene name given in Supporting Information Table S1). Two of these
genes encode proteins strongly associated with inflammation and
insulin resistance. Serum amyloid A3 (SAA3) is a proinflammatory
and lipolytic cytokine secreted by macrophages and adipocytes that
promotes macrophage recruitment (20). Plasminogen activator
inhibitor-1 (serpine-1/PAI-1) is a serine protease inhibitor that is
associated with obesity, inflammation, and insulin resistance in
rodents and humans (21). In contrast, adipsin, a complement factor
secreted by adipocytes whose expression is increased by PPARc
agonists (22), but decreased in obesity (23), was expressed at higher
levels in Siah2KO mice. Siah2-mediated changes in inflammatory
markers also include down-regulation of tcirg1, a T lymphocyte
membrane ATPase that promotes proinflammatory T cell activation
(24), and up-regulation of fox3p, a marker of the anti-inflammatory
regulated T (Treg) cells (Figure 5C).
Blunted proinflammatory responses to obesity in Siah2KO adipose tis-
sue were further demonstrated by comparing inflammatory gene
expression in the LFD- and HFD-fed mice (Figure 5D). Although
inflammatory marker gene expression was consistently reduced in the
HFD-fed Siah2KO adipose tissue, gene expression in the LFD
Siah2KO adipose tissue was either unchanged or increased, including
adam 8, an extracellular matrix metallopeptidase up-regulated with
adipose tissue inflammation (25), and col6a2, a collagen VI subunit.
Reduced fibrosis and stress kinase activation in
Siah2KO mice
The extracellular matrix surrounding adipocytes contributes to the rela-
tionship between adipocyte expandability and developing adipose
Figure 4 Siah2 controls adipose tissue inflammation. WT and Siah2KO epididymal adipose tissue was evaluated using microarray analysis of gene expression.
(A) Most significant biological functions affected by Siah2 determined by Ingenuity software analysis. (B) Hierarchical clustering of the top 50 genes up- or
down-regulated by Siah2 in the LFD- or HFD-fed mice. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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tissue inflammation with obesity (2). The inflammatory response to
adipocyte hypertrophy leads to excess collagen deposition and adi-
pose tissue fibrosis, restricting the ability of the adipocytes to
expand further (26). Khan et al. showed collagens IV and VI are
generally expressed at high levels in the visceral fat depot of db/db
mice and are down-regulated by PPARc activation or overexpres-
sion of adiponectin (2). Furthermore, we previously demonstrated
that Siah2 has a promoting role for tissue fibrosis through colla-
gens in wound healing (27). While the collagen IV subunit col4a6
was up-regulated in Siah2KO adipose tissue, collagen VI subunit
col6a2 was reduced and col6a3 was unchanged (Figure 6A).
Adam8 was twofold lower in the Siah2KO visceral fat. Lumican, a
proteoglycan promoting fibrosis that is negatively regulated by
PPARc, was reduced although decorin, another proteoglycan that
regulates fibrosis (2), was unchanged (Figure 6A).
To determine whether changes in expression of inflammatory
markers and extracellular matrix components correlate with reduced
fibrosis, trichrome staining of the Siah2KO epididymal adipose tis-
sue was compared to WT (Figure 6B). The widespread collagen
deposition present in WT was absent in the Siah2KO visceral fat.
Consistent with reduced fibrosis, there were significantly fewer mac-
rophages configured as crown-like structures surrounding adipocytes
in the Siah2KO adipose tissue (Figure 6B, Iba-1).
Figure 5 Siah2 regulates inflammatory gene expression in adipose tissue of HFD-fed mice. Gene expression of markers of (A) inflammation, (B) cytokines and
chemokines, and (C) T lymphocytes was assayed in the HFD-fed mice or (D) compared between the LFD- and HFD-fed mice using real-time qRT-PCR. Sta-
tistical significance compared to WT, *P<0.01; **P <0.001.
Original Article Obesity
OBESITY BIOLOGY AND INTEGRATED PHYSIOLOGY
www.obesityjournal.org Obesity | VOLUME 23 | NUMBER 11 | NOVEMBER 2015 2229
Fibrotic changes with adipocyte expansion in obesity cause mechan-
ical stress that activates stress kinase signaling pathways, including
the Jun N-terminal kinase (JNK) and extracellular signal-regulated
(ERK p42/44) MAPK pathways (5). Activation of JNK and NFjB
by TNFa elicits proinflammatory changes in obese adipose tissue
(1) and in vitro TNFa-mediated insulin resistance depends on activa-
tion of the ERK p42/44-MAPK pathway in adipocytes (28). Figure
6C demonstrates that activation of these key signaling pathways was
attenuated in the obese Siah2KO animals.
Partial activation of PPARc in the Siah2KO
adipose tissue
PPARc transcriptional activity plays a pivotal role in regulating adi-
pose tissue inflammation in response to chronic energy excess
(11,29). Our studies in 3T3-L1 adipocytes indicate Siah2 regulates
expression of a subset of PPARc target genes and affects ligand-
dependent degradation of PPARc proteins (10). Therefore, we assayed
the expression of a subset of PPARc target genes that were differen-
tially regulated in our microarray analysis. Although classic markers
of adipogenesis such as pck-1 and fabp4 were down-regulated in the
Siah2KO epididymal fat, several genes encoding proteins involved in
fatty acid transport and storage (lpl, cd36, soat1) and lipid synthesis
(fasn, lipin1) were up-regulated (Figure 7A). While the increase in lpl
expression was modest, expression of fasn, cd36, lipin1, and soat1
was increased two- to fivefold. Activation of PPARc was not
associated with regulation of PPARc1 or PPARc2 gene expression in
the Siah2KO adipose tissue (Figure 7B) but did correlate with
increased PPARc protein levels (Figure 7C-E) and decreased PPARc
ubiquitylation (Figure 7F,G). Although identified as a target of Siah2
in vitro (30), nuclear corepressor-1 (NCoR) levels were decreased,
and the levels of Siah2 target proteins, histone deacetylase-3
(HDAC3) (31), and prolyl-3-hydroxylase (PHD3) (32) were unaltered.
Discussion
The ubiquitin-proteasome system is well described as a critical
regulator of immune responses (6). For example, TNFa-mediated
activation of NF-jB is regulated by multiple ubiquitin ligases,
including several TNF receptor-associated factors (TRAFs 2, 5,
and 6) as well as A20/TNFa-induced protein-3 (6) and ITCH, a
JNK phosphorylation-dependent ligase that modulates TNFa sig-
naling (33). Much less is known about how ubiquitin ligases affect
the chronic inflammation that occurs in response to obesity. In this
study, we report the relationship between obesity-related adipocyte
hypertrophy, adipose tissue inflammation, and insulin sensitivity is
regulated by the ubiquitin ligase Siah2. Although Siah2KO adipo-
cytes trended larger than WT, deletion of Siah2 protected mice
with diet-induced obesity from adipose tissue inflammation, and
insulin sensitivity in the obese Siah2KO animals was comparable
to lean WT. The striking decrease in proinflammatory cytokine
and chemokine expression along with reduced fibrosis and crown-
like structures and elevated levels of regulatory T cell markers
indicates Siah2 is necessary for adipocyte hypertrophy to elicit the
inflammatory changes in obese adipose tissue that lead to insulin
resistance. Several mechanisms may underlie the effect of Siah2
on the relationship between adipocyte hypertrophy and insulin
resistance.
Although a sustained influx of M1-like macrophages in adipose tis-
sue restricts adipocyte expansion (2,34), macrophage infiltration is
essential for healthy adipose tissue remodeling in response to excess
energy intake. As adipocytes expand, dysfunctional enlarged adipo-
cytes are removed by macrophages and replaced by newly formed
adipocytes (35). However, the early distribution toward larger adipo-
cytes in the lean and obese Siah2KO mice and our in vitro studies
showing loss of Siah2 impairs adipogenesis (10) argue against accel-
erated adipose tissue remodeling in the Siah2KO animals. Instead,
the broad transcriptional response in markers of inflammation sug-
gests Siah2 regulates the influx, production, or activation of proin-
flammatory immune cells. Initial studies of Siah2 found Siah2 dele-
tion enhances expansion of bone marrow-derived myeloid progenitor
cells in vitro without altering the levels of myeloid cells in vivo
(12). Our study found that Siah2 deficiency substantially reduces
expression of trem2 in adipose tissue, which encodes a protein found
on monocyte-derived dendritic cells that promotes myeloid cell acti-
vation (36). The possibility that Siah2 is affecting inflammation via
Figure 6 Siah2 deficiency decreases markers of adipocyte dysfunction in obesity. Indicators of adipocyte dysfunction were assayed in epididymal adipose tissue
from HFD-fed mice. (A) Extracellular matrix components were determined using real-time qRT-PCR. Statistical significance compared to WT, *P< 0.05;
**P< 0.01. (B) Fibrosis was determined using trichrome staining of collagen, and crown-like structures were visualized using anti-Iba-1 immunostaining of macro-
phages. (C) Stress kinase activation was determined via Western blot analysis. b-actin is included as a loading control. [Color figure can be viewed in the online
issue, which is available at wileyonlinelibrary.com.]
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TREM-2 is supported by evidence that dendritic cells promote mac-
rophage infiltration of adipose tissue (37).
Our data also show the absence of proinflammatory changes in the
obese Siah2KO visceral adipose tissue corresponds to increased lipid
storage capacity in the enlarged adipocytes. Isolated Siah2KO adipo-
cytes were more sensitive to the anti-lipolytic effect of insulin, and
this was reflected in vivo by reduced circulating fatty acids and tri-
glyceride levels. The “lipid steal” hypothesis proposes that PPARc
activation in adipose tissue enhances the ability of adipocytes to
store excess lipids in obesity (11). This protects other insulin-
responsive tissues from reactive lipids, resulting in improved insulin
sensitivity. Although markers of adipogenesis such as fabp4, pck1,
and adiponectin are not increased, PPARc target genes involved in
lipid uptake, lipid synthesis, and lipid storage are up-regulated in the
adipose tissue. Increased lipid storage in the hypertrophied adipo-
cytes is consistent with our observation that genotype significantly
contributed to decreased energy expenditure in the Siah2KO obese
mice independent of body composition. Several adipokines influ-
enced by PPARc activation that impact adipose tissue inflammation
are also regulated by Siah2. Higher adipsin levels and lower mcp-1,
saa3, and pai-1 levels are associated with ligand activation of
PPARc (11), but unaltered expression of adiponectin and other
PPARc targets such as pck-1 suggests that a role for PPARc tran-
scriptional activity in Siah2-mediated regulation of inflammation
does not occur via classical PPARc ligand binding. This is consist-
ent with elevated PPARc protein levels accompanied by only modest
reductions in PPARc ubiquitylation. PPARc-mediated changes in
Figure 7 Loss of Siah2 selectively regulates PPARc target genes involved in lipid metabolism and alters PPARc protein levels. All measurements were carried out
in epididymal adipose tissue from HFD-fed mice. (A) A subset of PPARc target genes selected based on microarray analysis was analyzed via real-time qRT-
PCR. (B) Gene expression of PPARc1, PPARc2, or PPARc1 and PPARc2 combined. (C) Steady-state level of PPARc proteins and selected Siah2 target proteins.
(D) PPARc protein levels from expanded number of mice. b-actin is included as a loading control in panels C and D. (E) Quantification of PPARc protein levels in
panel D. (F) Ubiquitin modification of PPARc determined by Western blot analysis of PPARc (IP PPARc, IB PPARc) or ubiquitin (IP PPARc, IB ubiquitin) after immu-
noprecipitation of PPARc from WT or Siah2KO epididymal adipose tissue. (G) Quantification of high-molecular-weight PPARc ubiquitin conjugates. Statistical sig-
nificance compared to WT, *P< 0.05; **P< 0.01.
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lipid storage capacity can be regulated by TNFa (1,29). TNFa inhib-
its PPARc activity via multiple mechanisms (29), including caspase-
dependent degradation of PPARc proteins (38,39). Moreover, Siah
proteins are structurally similar to the TRAF ubiquitin ligases that
regulate TNFa signaling (40). Therefore, reduced caspase cleavage
of PPARc proteins may also regulate PPARc protein levels and
activity in the Siah2KO animals.
The well-described role of Siah2 in regulating cellular responses to
hypoxia (32) suggests Siah2 deletion inhibits hypoxia-related adipose
tissue fibrosis and the subsequent influx of immune cells (26). This
possibility is supported by our evidence that fibrosis was reduced in
the adipose tissue of obese Siah2KO mice. A Siah2-mediated effect
on hypoxia is unlikely to occur via a HIF-1a-dependent pathway since
Siah2 deletion does not affect the protein levels of PHD3, the Siah2
target protein responsible for targeting HIF-1a for degradation. How-
ever, Siah2 also affects hypoxia responses via HIF-1a-independent
pathways that involve MAPK signaling (32), which was reduced in
the Siah2KO adipose tissue. A Siah2-dependent mechanism influenc-
ing the relationship between adipocyte hypertrophy and insulin sensi-
tivity that indirectly affects inflammation is an attractive possibility
given our results showing glucose tolerance and insulin sensitivity
were also improved in the lean Siah2KO mice without consistent
changes in inflammatory markers.
Future studies that take advantage of adipocyte-specific deletion of
Siah2 are needed to fully address the mechanisms by which Siah2 is
regulating adipose tissue inflammation, lipid metabolism, and insulin
sensitivity in adipose tissue. Nevertheless, our data clearly establishes
a role for Siah2 in determining the inflammatory response to adipo-
cyte hypertrophy and regulation of insulin sensitivity in obesity.O
VC 2015 The Obesity Society
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